Quantitation of serum IgE by using chimeras of human IgE receptor and avian immunoglobulin domains (original) (raw)
Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells
Steve Coats
Cellular and Molecular Immunology, 2015
View PDFchevron_right
Molecular and cellular targets of anti-IgE antibodies
Reto Crameri
Allergy, 2005
View PDFchevron_right
IgE antibody-specific activity in human allergic disease
eva hamilton
Immunologic Research, 2010
View PDFchevron_right
A molecular model of type I allergy: Identification and characterization of a nonanaphylactic anti-human IgE antibody fragment that blocks the IgE-FcϵRI interaction and reacts with receptor-bound IgE
Ken Roux
Journal of Allergy and Clinical Immunology, 2001
View PDFchevron_right
Current and future applications of the anti-IgE antibody omalizumab
Cristoforo Incorvaia
Biologics: Targets & Therapy, 2008
View PDFchevron_right
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
N. Do, Yehong Wang
Science Translational Medicine, 2014
View PDFchevron_right
Development and characterization of a novel anti-IgE monoclonal antibody
sheng hou
Biochemical and Biophysical Research Communications, 2010
View PDFchevron_right
Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5)
Ng Chun Hou
International journal of biomedical science : IJBS, 2009
View PDFchevron_right
Circulating IgG autoanti-IgE antibodies in atopic patients block the binding of IgE to its low affinity receptor (CD23)
Farouk Shakib
Journal of Clinical Pathology-molecular Pathology, 1995
View PDFchevron_right
A soluble form of the high affinity IgE receptor, Fc-epsilon-RI, circulates in human serum
Edda Fiebiger, Barbara Platzer
2011
View PDFchevron_right
Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases
Mario Cazzola
Current Drug Target -Inflammation & Allergy, 2004
View PDFchevron_right
Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab
sheng hou
Biochemical and Biophysical Research Communications, 2008
View PDFchevron_right
Anti-IgE Monoclonal Antibody: a new approach to the treatment of allergic respiratory diseases
Claudio F Donner
View PDFchevron_right
A monoclonal anti-IgE antibody against an epitope (amino acids 367-376) in the CH3 domain inhibits IgE binding to the low affinity IgE receptor (CD23)
Prof. Dr. John Wijdenes
Journal of immunology (Baltimore, Md. : 1950), 1988
View PDFchevron_right
Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein
Hector Perez
Journal of Allergy and Clinical Immunology, 2004
View PDFchevron_right
Attenuation of IgE Affinity for Fc RI Radically Reduces the Allergic Response in Vitro and in Vivo
DAVID DOMBROWICZ
Journal of Biological Chemistry, 2008
View PDFchevron_right
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
Alistair Henry
The Journal of biological chemistry, 2017
View PDFchevron_right
Low-affinity IgE receptor (FcεRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complex
Raja'a Al-Attiyah
International Immunopharmacology, 2009
View PDFchevron_right
The who, where, and when of IgE in allergic airway disease
Melissa Dullaers
Journal of Allergy and Clinical Immunology, 2012
View PDFchevron_right
Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE
Maria Byazrova
Frontiers in Immunology, 2021
View PDFchevron_right
An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcγRIIb
Mark Cragg
The Journal of allergy and clinical immunology, 2018
View PDFchevron_right
Monoclonal antibodies to three distinct epitopes on human IgE: Their use for determination of allergen-specific IgE
João Carlos
Journal of Immunological Methods, 1984
View PDFchevron_right
The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics
Daniel Gygax
Journal of Clinical Investigation, 1997
View PDFchevron_right
Attenuation of IgE Affinity for FcϵRI Radically Reduces the Allergic Response in Vitro and in Vivo
DAVID DOMBROWICZ
Journal of Biological …, 2008
View PDFchevron_right
Recombinant soluble form of the human high-affinity receptor for IgE prevents anaphylactic shock in mice
Chisei Ra
Journal of Allergy and Clinical Immunology, 1996
View PDFchevron_right
Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving Omalizumab (Xolair) therapy
eva hamilton
Journal of Immunological Methods, 2005
View PDFchevron_right
Rapid polyclonal desensitization with antibodies to IgE and FcεRIα
Marat Khodoun
Journal of Allergy and Clinical Immunology, 2013
View PDFchevron_right
IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE
Ulrich Pirron
European Journal of Immunology, 1990
View PDFchevron_right
Can IgE-mediated allergic diseases be prevented by using allergen-specific IgG antibodies?
Hiroshi Tachibana
Medical Hypotheses, 2011
View PDFchevron_right
A novel IgE-neutralizing antibody for the treatment of severe uncontrolled asthma
Helena Käck, Feenagh Keyes, Sophia Karagiannis
mAbs, 2014
View PDFchevron_right